![](/images/general/no_picture/200_user.png)
Carlos R Ortiz Rodriguez
Examiner (ID: 10220, Phone: (571)272-3766 , Office: P/2127 )
Most Active Art Unit | 2119 |
Art Unit(s) | 2125, 2119, 2123, 2127, 2122 |
Total Applications | 923 |
Issued Applications | 647 |
Pending Applications | 77 |
Abandoned Applications | 199 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 12880372
[patent_doc_number] => 20180185299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => THE USE OF DIPHENOL IN PREPARATION OF MEDICINES FOR PREVENTION AND TREATMENT OF CEREBRAL ISCHEMIA
[patent_app_type] => utility
[patent_app_number] => 15/543473
[patent_app_country] => US
[patent_app_date] => 2016-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15543473
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/543473 | THE USE OF DIPHENOL IN PREPARATION OF MEDICINES FOR PREVENTION AND TREATMENT OF CEREBRAL ISCHEMIA | Mar 10, 2016 | Abandoned |
Array
(
[id] => 10987369
[patent_doc_number] => 20160184314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-30
[patent_title] => 'Drug Combinations and Uses in Treating a Coughing Condition'
[patent_app_type] => utility
[patent_app_number] => 15/063465
[patent_app_country] => US
[patent_app_date] => 2016-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61583
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15063465
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/063465 | Drug combinations and uses in treating a coughing condition | Mar 6, 2016 | Issued |
Array
(
[id] => 13325829
[patent_doc_number] => 20180214452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => COMPOSITION FOR PREVENTION OR TREATMENT OF INTRACTABLE EPILEPSY COMPRISING mTOR INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 15/555622
[patent_app_country] => US
[patent_app_date] => 2016-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15555622
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/555622 | COMPOSITION FOR PREVENTION OR TREATMENT OF INTRACTABLE EPILEPSY COMPRISING mTOR INHIBITOR | Mar 6, 2016 | Abandoned |
Array
(
[id] => 11735991
[patent_doc_number] => 09700561
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-11
[patent_title] => 'Drug combinations and uses in treating a coughing condition'
[patent_app_type] => utility
[patent_app_number] => 15/061656
[patent_app_country] => US
[patent_app_date] => 2016-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61584
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15061656
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/061656 | Drug combinations and uses in treating a coughing condition | Mar 3, 2016 | Issued |
Array
(
[id] => 12238379
[patent_doc_number] => 20180071243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'USE OF FERRIC CITRATE IN THE TREATMENT OF IRON-DEFICIENCY ANEMIA'
[patent_app_type] => utility
[patent_app_number] => 15/553348
[patent_app_country] => US
[patent_app_date] => 2016-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38533
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15553348
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/553348 | USE OF FERRIC CITRATE IN THE TREATMENT OF IRON-DEFICIENCY ANEMIA | Mar 2, 2016 | Abandoned |
Array
(
[id] => 12238417
[patent_doc_number] => 20180071280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'MODULATORS OF CELL DEATH PROCESSES'
[patent_app_type] => utility
[patent_app_number] => 15/553810
[patent_app_country] => US
[patent_app_date] => 2016-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 32903
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15553810
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/553810 | MODULATORS OF CELL DEATH PROCESSES | Feb 24, 2016 | Abandoned |
Array
(
[id] => 10820423
[patent_doc_number] => 20160166587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'AMELIORATION OF INTESTINAL FIBROSIS AND TREATMENT OF CROHN\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 15/051850
[patent_app_country] => US
[patent_app_date] => 2016-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10000
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15051850
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/051850 | Amelioration of intestinal fibrosis and treatment of Crohn's disease | Feb 23, 2016 | Issued |
Array
(
[id] => 10820363
[patent_doc_number] => 20160166526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'COMPOUNDS FOR SUPPRESSING A PERIPHERAL NERVE DISORDER INDUCED BY AN ANTI-CANCER AGENT'
[patent_app_type] => utility
[patent_app_number] => 15/047965
[patent_app_country] => US
[patent_app_date] => 2016-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21789
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15047965
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/047965 | COMPOUNDS FOR SUPPRESSING A PERIPHERAL NERVE DISORDER INDUCED BY AN ANTI-CANCER AGENT | Feb 18, 2016 | Abandoned |
Array
(
[id] => 10812012
[patent_doc_number] => 20160158173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'METHODS FOR TREATING BRAIN INJURY'
[patent_app_type] => utility
[patent_app_number] => 15/046676
[patent_app_country] => US
[patent_app_date] => 2016-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 6958
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15046676
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/046676 | Methods of treating tinnitus | Feb 17, 2016 | Issued |
Array
(
[id] => 12486546
[patent_doc_number] => 09993453
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-12
[patent_title] => Dosage forms and therapeutic uses L-4-chlorokynurenine
[patent_app_type] => utility
[patent_app_number] => 15/018219
[patent_app_country] => US
[patent_app_date] => 2016-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4769
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15018219
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/018219 | Dosage forms and therapeutic uses L-4-chlorokynurenine | Feb 7, 2016 | Issued |
Array
(
[id] => 10812030
[patent_doc_number] => 20160158190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'Methods and Compositions for Inhibition of ATR and FANCD2 Activation'
[patent_app_type] => utility
[patent_app_number] => 15/016690
[patent_app_country] => US
[patent_app_date] => 2016-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 12060
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15016690
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/016690 | Methods and compositions for inhibition of ATR and FANCD2 activation | Feb 4, 2016 | Issued |
Array
(
[id] => 13507605
[patent_doc_number] => 20180305345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => COMPOSITIONS AND METHODS FOR ENHANCING ONCOLYTIC VIRUS EFFICACY
[patent_app_type] => utility
[patent_app_number] => 15/542480
[patent_app_country] => US
[patent_app_date] => 2016-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19620
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15542480
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/542480 | COMPOSITIONS AND METHODS FOR ENHANCING ONCOLYTIC VIRUS EFFICACY | Jan 25, 2016 | Abandoned |
Array
(
[id] => 10805144
[patent_doc_number] => 20160151301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'Compositions and methods for treating alzheimer`s disease and related disorders and promoting a healthy nervous system'
[patent_app_type] => utility
[patent_app_number] => 15/004078
[patent_app_country] => US
[patent_app_date] => 2016-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 14217
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15004078
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/004078 | Compositions and methods for treating alzheimer`s disease and related disorders and promoting a healthy nervous system | Jan 21, 2016 | Abandoned |
Array
(
[id] => 12117191
[patent_doc_number] => 20180000778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'SMALL MOLECULE ANTAGONISTS OF DUSP5 AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/542364
[patent_app_country] => US
[patent_app_date] => 2016-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15308
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15542364
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/542364 | SMALL MOLECULE ANTAGONISTS OF DUSP5 AND METHODS OF USE | Jan 14, 2016 | Abandoned |
Array
(
[id] => 16259892
[patent_doc_number] => 10751300
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-25
[patent_title] => Composition and method for treating seizure disorders
[patent_app_type] => utility
[patent_app_number] => 15/104556
[patent_app_country] => US
[patent_app_date] => 2016-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1488
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15104556
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/104556 | Composition and method for treating seizure disorders | Jan 13, 2016 | Issued |
Array
(
[id] => 13410037
[patent_doc_number] => 20180256561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => Pharmaceutical Combination
[patent_app_type] => utility
[patent_app_number] => 15/542125
[patent_app_country] => US
[patent_app_date] => 2016-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8633
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15542125
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/542125 | Pharmaceutical Combination | Jan 10, 2016 | Abandoned |
Array
(
[id] => 10774743
[patent_doc_number] => 20160120899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-05
[patent_title] => 'Drug Combinations and Uses in Treating a Coughing Condition'
[patent_app_type] => utility
[patent_app_number] => 14/991892
[patent_app_country] => US
[patent_app_date] => 2016-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36370
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14991892
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/991892 | Drug Combinations and Uses in Treating a Coughing Condition | Jan 7, 2016 | Abandoned |
Array
(
[id] => 12831715
[patent_doc_number] => 20180169077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR FIBROMYALGIA
[patent_app_type] => utility
[patent_app_number] => 15/542167
[patent_app_country] => US
[patent_app_date] => 2016-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3385
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15542167
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/542167 | Prophylactic and/or therapeutic agent for fibromyalgia | Jan 7, 2016 | Issued |
Array
(
[id] => 13440621
[patent_doc_number] => 20180271853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => Method of Use for Inhibitors of Epidermal Growth Factor Receptor Variant III
[patent_app_type] => utility
[patent_app_number] => 15/542328
[patent_app_country] => US
[patent_app_date] => 2016-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4640
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15542328
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/542328 | Method of Use for Inhibitors of Epidermal Growth Factor Receptor Variant III | Jan 7, 2016 | Abandoned |
Array
(
[id] => 10767792
[patent_doc_number] => 20160113949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-28
[patent_title] => 'DARUNAVIR FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/990621
[patent_app_country] => US
[patent_app_date] => 2016-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5575
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14990621
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/990621 | DARUNAVIR FORMULATIONS | Jan 6, 2016 | Abandoned |